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Background: Blackwater fever (BWF) is one of the severe forms of malaria. This complication was first described
among non-immune European expatriates in the malaria endemic areas. Recently, resurgence of this form of
malaria has been reported among the indigenous populations. The objective of this study was to investigate the
risk factors among BWF patients.
Methods: A case–control study was conducted between in four hospitals located in Kinshasa, Democratic Republic
of Congo from January 2010 to December 2011. One hundred and twenty nine children were recruited with 43
(cases) and 86 (control).
Results: No significant difference in the gender and age distribution was observed between the case and control).
The sex-ratio male to female in the case group and control group was respectively 1:1.0 and 1:1.1. The mean age
was 8.62 years (SD = 3.84) in patients with haemoglobinuria and 8.55 years (SD = 3.77) in the control group. No
difference in frequency of co-infection with Plasmodium falciparum and Plasmodium malariae was observed
between the two groups. Significant differences in haemoglobin, haematocrit, creatinine, urea and platelets levels
were observed between the two groups (p < 0.001), but not for blood group and lactate dehydrogenase (LDH)
level. Majority of the BWF cases occurred during the rainy season (88.4%). Treatment with quinine (95.3%) was
significantly associated with cases (p < 0.001). Seven (16.2%) of the haemoglobinuric children developed acute renal
failure.
Conclusion: Rainy season, low parasitaemia and quinine ingestion were the major risk factors significantly
associated with haemoglobinuria. Acute renal failure was observed as the major complication of BWF.
Keywords: Blackwater fever, Children, Quinine ingestion, Parasitaemia, Kinshasa, Democratic Republic of CongoBackground
Despite tremendous improvement in control measures
in the last decade, malaria still remains a major public
health problem in the world, with sub-Saharan Africa ac-
counting for 81% of the 216 millions of malaria cases
reported in the world in 2010 [1]. According to World
Health Organization (WHO) global estimations in 2010,
655.000 deaths occurred and 86% of them among chil-
dren less than five years old [1]. Plasmodium falciparum
is the main species associated with complicated malaria
cases such as blackwater fever (BWF) [2].* Correspondence: jbodi1@yahoo.fr
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reproduction in any medium, provided the orBWF is a clinical syndrome characterized by an acute
intravascular haemolysis presenting with dark urine
(haemoglobinuria), jaundice, anaemia and fever. Abdom-
inal pain, vomiting, hepatomegaly, splenomegaly, pain in
the back or limbs, dyspnea, tachycardia, generalized mal-
aise and dizziness can also be found. However, patients can
also be asymptomatic [3,4]. The ingestion of quinine by
non-immune residents affected with P. falciparum in en-
demic areas was associated with BWF [5-9]. Isolated cases
of BWF have also been reported from patients treated with
other anti-malarial drugs, such as halofantrine, mefloquine
and artemether-lumefantrine [10-13].
BWF was first described in non-immune European ex-
patriates who lived in endemic malaria regions [5,6,14-18].
Rare in indigenous populations, the first cases have beend. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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dren in Senegal [19]. Recently, resurgence of this disease
was reported in other African populations living in areas
with stable malaria transmission who are supposed to
have sufficient immunity against malaria [3,19-22]. In the
Democratic Republic of Congo (DRC), BWF caused acute
renal failure in children with more than 22% of mortality
rate [23,24].
The pathogenesis of BWF is complex. Inadequate mal-
arial immunity, misuse of quinine and G6PD deficiency
have been associated with the occurrence of BWF [5-9].
G6PD status was already studied in DRC where the
prevalence varies from 6.1% to 23.4% [25].
The objective of this study was to investigate and de-
termine the risk factors associated with BWF among
children with malaria in DRC. The epidemiological, im-
munological and genetic characteristics of BWF patients
was investigated in comparison to those with uncompli-
cated malaria.
Methods
Subjects, study design and case definitions
This case–control study was conducted in four paediat-
ric health facilities in Kinshasa, namely Pediatrics De-
partment of Kinshasa University Hospital, Kimbanseke
Hospital, Bondeko Hospital and General Provincial Hos-
pital of Kinshasa. Each of these health facilities repre-
sents a stratum of the four administrative subdivisions
of Kinshasa, a town of at least 8 million of inhabitants
located in an endemic malaria area with a stable trans-
mission. Kinshasa, the capital of DRC, is characterized
by two distinct seasons, a rainy season with an average
of 1350 mm of annual rainfall during the months of
September to May and a hot dry season from June to
August.
Children with BWF were recruited as cases, while
those with uncomplicated malaria according to WHO
definition [1] were enrolled as the control in the study.
For each case, two control patients matched for age, sex
and place of residence were recruited into the study.
The inclusion criteria for BWF cases selection included
presence of haemoglobin in the dark urine of febrile pa-
tients with jaundice and anemic among patient with
microscopically confirmed P. falciparum malaria.
Data collection procedure and blood analysis
After obtaining an informed consent from the parent,
each child’s caregiver was interviewed using a structured
standard project questionnaire to obtain detailed history
of the participants disease or from the child if old he/she
enough. A complete physical examination was carried
out on each child with focus on detection of anemia,
jaundice, hepatomegaly and splenomegaly. Five ml of
venous blood sample was drawn from each studyparticipant into an EDTA tube, used to determine
haemoglobin, haematocrit, haemoglobin electrophoresis,
G6PD screening, blood group, alanine aminotransferase
(ALAT), aspartate aminotransferase (ASAT), lactate de-
hydrogenase (LDH), bilirubin levels, urea and creatinine.
Packed cell volume (PCV) was determined using the ca-
pillary method and spinning in a Hawksley micro-
haematocrit centrifuge at 11,000 g for 5 minutes at room
temperature. The PCV was then read with a haematocrit
reader.
Thick and thin films were fixed with Giemsa for mal-
aria parasite screening and identification. All participants
in the study were screened for Sickle cell trait and
glucose-6-phosphate dehydrogenase deficiency (G6PD).
G6PD was determined using the fluorescent spot test
method of Beutler and Mitchell (Biolabo, france) [26].
For the control group, G6PD was screened at admission
but for the case group, G6PD was screened three
months after the acute haemolysis crisis.
Urine collection procedure and urinalysis
All participants were requested to give 20 ml of urine at
recruited time and this was then assessed for haemo-
globinuria using three test strips. The Test strips used in
this study were; Medi Test Combi 9® (Macherey Nagel,
Germany), the Urine 9 parameters Combur Test (Cy-
press Diagnostics, Belgium) and the Urine 9 parameters
(Cypress Diagnostics, Belgium), and the results obtained
using this strips was compared with the spectrophotom-
eter results (the gold standard). The test strips were
dipped into 20 ml of fresh urine sample for approxi-
mately one second, then drawn across the rim of the
container to remove the excess urine. After 30 to 60 sec-
onds, the strip was assessed using the colour scale, with
the test being considered positive if the colour changed
from yellow to green. Renal failure was defined as urine
output < 0.5 ml/kg for 24 h or a persisting high plasma
creatinine concentration above the age-related normal
range, after rehydration [27].
Data management and analysis
All data obtained from the study questionnaire, clinical
results were manually entered into a microcomputer and
analysed using the Epi-Info 7 Version 2002 (CDC). After
data cleaning (control for quality and coherence), they
were exported on SPSS 18.0 for further analysis. De-
scriptive analysis were used to get mean for quantitative
and proportion for all the qualitative variables. The con-
fidence interval at 95% was calculated. Associations be-
tween variables and haemoglobinuria was evaluated
using chi-square and fisher exact test (for the cell with
expected frequency less than 5 in two by two table more
than 20%). The comparison of continuous variables was
calculated using the Student T test. Logistic regression
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BWF occurrence and to measure the strength of associ-
ation of each determinants (adjusted odds ratio). Statis-
tical significance level was set at p = 0.05.
Ethical consideration
Ethical approval for the study was granted by the Ethical
Committee of the Public Health School of the University
of Kinshasa, Kinshasa, DRC (ESP/CE/027B/2011) and
the institutional review committee of Institute of Trop-
ical Medicine (NEKKEN), Nagasaki University, Japan. A
written consent signed by parents was obtained from
each of the subjects recruited before their inclusion.
Results
A total of 129 children, 43 with haemoglobinuria and 86
with uncomplicated malaria were recruited into theTable 1 Socio-demographic, epidemiological characteristics a
episode of haemoglobinuria
Positive n (%) Nega
Age distribution
- ≤ 5 ans 8(18.6) 2
- > 5 ans 35(81.4) 6
Sex. n
- Male 21(48.8) 4
- Female 22(51.2) 4
G6PD Status (UI/L)
Normal 35(81.4) 5
Deficiency 8(18.6) 3
LDH (UI/L)
< 200 20(46.5) 4
200 à 400 14(32.6) 3
> 400 9(20.9) 1
Blood group
A 7(16.3) 2
AB 3(7.0)
B 8(18.6) 1
O 25(58.1) 4
Season
Rainy 38(88.4) 5
Dry 5(11.6) 3
Plasmodium
Falciparum 37(86.0) 7
Falciparum and malariae 6(14.0) 1
Parasitaemia (parasites/microliter)
Low 32(78.0) 4
High 9(22.0) 4study over the 24 months (January 2010 to December
2011) of the study period. In general, the study partici-
pants comprises 68 (52.7%) females and 61 (47.3%)
males with a male to female sex-ratio of 1:1.1 and the
age ranging from 2 to 15 years with a mean age of 8.57
(SD = 3.73) years (Table 1). The mean age of the patients
with haemoglobinuria was 8.62 (SD = 3.84) years while
that of the uncomplicated malaria was 8.55 (SD = 3.77)
years (Table 1). The sex-ratio male to female in the case
group and control group was respectively 1:1.0 and
1:1.1. No significant difference in the gender and age dis-
tribution was observed between the case and control.
Infection was analysed for the case and control groups.
Mono-infection with P. falciparum was observed in 37
cases (86%) of haemoglobinuric patients, while six cases
were observed to have co-infection of P. falciparum and
Plasmodium malariae (14%). Among the control groupnd malaria parasitaemia among study children and
Haemoglobinuria
tive n (%) All n (%) OR (IC95%) p
NS
0(23.3) 28(21.7) 1
6(76.7) 101(78.3) 1.33 (0.53–3.32)
NS
0(46.7) 61(47.3) 1.10 (0.53–2.28)
6(53.5) 68(52.7) 1
0.017
2(60.5) 87(67.4) 2.86 (1.86–6.91)
4(39.5) 42(32.6) 1
NS
0(46.5) 60(46.5) 1.29 (0.57–2.91)
6(41.9) 50(38.8) 1
0(11.6) 19(14.7) 2.31 (0.78–6.89)
NS
3(26.8) 30(23.3) 0.57 (0.22–1.52)
6(7.0) 9(7.0) 0.94 (0.14–4.87)
0(11.6) 18(14.0) 1.50 (0.53–4.29)
7(54.6) 72(55.7) 1
< 0.001
1(59.3) 89(69.0) 5.22 (1.87–14.56)
5(40.7) 40(31.0) 1
NS
3(84.9) 110(85.3) 1.10 (0.39–3.12)
3(15.1) 19(14.7) 1
0.005
3(51.8) 76(61.3) 3.31 (1.41–7.78)
0(48.2) 48(38.7) 1
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observed to have mono-infection with P. falciparum,
while 13 children (15.1%) were observed to have co-
infection of P. falciparum and P. malariae. The mean
parasite counts of patients with haemoglobinuria were
slightly lower than those uncomplicated malaria with
statistically significant difference observed (OR = 3.31
(1.41–7.78), p < 0.05) (Table 1).
Distribution of blood group was analysed among the
study participants. Even though 55.7% of the study par-
ticipants were blood group O, no significant difference
in the distribution was observed between the case and
control groups (58.1.8% vs 54.6%) (Table 1). Distribution
of LDH levels as examined on admission was also
analysed and no significant difference was observed be-
tween the two groups (0R = 2.31 (0.78–6.21), p > 0.05)
(Table 1). When the levels of haemoglobin, haematocrit
and creatinine levels was compared, it was observed that
decreased haemoglobin and haematocrit was signifi-
cantly associated with increased risk for haemoglobin-
uria with an odds ratio of [OR: 25.08 (9.54–65.96)] and
[OR: 25.54 (9.54–65.96)], respectively (Table 2). On the
other hand, it was observed that an elevated creatinine
and urea levels were significantly associated with in-
creased risk of haemoglobinuria, with with an odds ratio
of [OR: 16.17 (1.97–735.3)] and [OR: 9.6 (3.21–28.68)]
(p < 0.001), respectively (Table 2). Urea to creatinine ra-
tio for all the cases was > 1:20 indicating prerenal failureTable 2 Laboratory features in study population
Positive (n = 43) Negative (n =
Haemoglobin (g/dl)
• patholigical (< 10) 33(76.7) 10(11.6)
• normal 10(23.3) 76(88.4)
Haematocrit (%)
• pathological (<30) 33(76.7) 10(11.6)
• normal 10(23.3) 76(88.4)
Platelets (number/mm3)
• pathological 3(7.0) 5(5.8)
• normal 40(93.0) 81(94.2)
Urea(mmol/L)
• pathological 16(37.2) 5(5.8)
• normal 27(62.8) 81(94.2)
Creatinine (mmol/L)
• pathological 7(16.3) 0(0)
• normal 36(83.7) 85(100)
Total bilirubin (mg/dl)
• pathological 12(27.9) 9(10.5)
• normal 31(72.1) 77(89.5)due to dehydration or shock. No case urea to creatinine
ratio <1:10 which indicates intrarenal kidney injury that
should require renal replacement treatment.
The majority of haemoglobinuria cases (BWF) oc-
curred during the rainy season (88.4%) [OR = 5.22
(1.87–14.20)], p <0.001), while 59.3%, of the uncompli-
cated malaria group occurred during the same season
(Table 1). On examination the anti-malarial drug taken
before among the haemoglobinuria group, 95.3% of the
cases were observed to have taken quinine [OR: 50.19
(10.75–234.42)] p < 0.001), while only three patients
(4.7%) were observed to have taken ACTs in the group
(Table 3).
In this series, it was observed that G6PD activity was
significantly low in control group [OR: 0.39 (0 12–
0.1.27), p = 0.015] (Table 4). The most common present-
ing symptoms for the children with haemoglobinuria
was observed to be dark urine (100%), jaundice (88.4%),
pallor (81.4%) and fever (72.1%), while that for the con-
trol group was observed to be 0%, 2.21%, 3.3%, and
100% (p < 0.001). Logistic regression analysis (Table 4)
showed that ingestion of quinine, low parasitaemia and
rainy season were the main risk factors associated with
the haemoglobinuria group (BWF).
Among the haemoglobinuria patients, seven children
(16.2%) developed acute renal failure (ARF), but only
two children had peritoneal dialysis performed because
of financial constraints. A conservative treatment wasHaemoglobinuria
86) All (n = 129) OR (IC95%) P
< 0.001
43(33.3) 25.08 (9.54–65.96)
86(66.7) 1
< 0.001
43(33.3) 25.08 (9.54–65.96)
86(66.7) 1
NS
8(6.2) 1.21 (0.18–6.60)
121(93.8) 1
< 0.001
21(16.3) 9.6 (3.21–28.68)
108(83.7) 1
< 0.001
7(5.5) 16.17 (1.97–753.3)
121(94.5) 1
0.011
21(16.3) 3.31 (1.27–8.65)
108(83.7) 1
Table 3 Anti-malarials, herbal plants and food intake before episode of haemoglobinuria
Haemoglobinuria
Positive (n = 43) Negative (n = 86) All (n = 129) OR (IC95%) p
Anti-malarials < 0.001
ACT 2(4.7) 60(69.8) 62(48.1) 1
quinine 41(95.3) 26(30.2) 67(51.9) 47.31 (10.64–210.3)
herbal plants 0.515
no 41(95.3) 85(98.8) 126(97.7) 1
yes 2(4.7) 1(1.2) 3(2.3) 4.15 (0.37–47.5)
Bean 0.01
no 37(86.0) 86(100) 123(95.3) 1
yes 6(14.0) 0(0) 6(4.7) 13.95 (1.62–119.9)
* ACT Artemisinin-based Combination Therapy.
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developing anuric acute renal failure and succumbing with
this complication (6.9%).
Discussion
In DRC, malaria is endemic, characterized by a high and
perennial transmission. However, there are few reports
on severe childhood malaria especially BWF. In the
present study, the clinical and biological observations
and the risk factors of BWF were evaluated for the first
time in Central Africa. This case–control study has
matched cases and controls for age, sex and location
area. It suggests that haemoglobinuria in severe malaria
is frequent in children above five years of age. The mean
age of these patients in this series was 8.62 (SD = 3.84)
years. These findings are comparable with previous stud-
ies, which reported the high incidence of BWF in this
age even in endemic stable areas where malaria immun-
ity is acquired after six years [3,19,28]. In Nigeria, Jelliffe
reported that this syndrome was three times prevalent
among children than adults, an observation which shows
an evidence of the delay in the acquisition of malarial
immunity [29].Table 4 Determinant factors of Black water fever by logistic r
Crude OR
(95%CI)
Anti-malarials
• ACT 1
• Quinine 47,31(10,64–210,3)
G6PD status
• Normal (≥276 UI/L) 1
• Deficiency (<276 UI/L) 0,35(0,14–0,54)
Parasitaemia (parasite/microl)
• Low 1
• High 0,30(0,13–0,71)
* ACT Artemisinin-based Combination Therapy.When BWF occurs among sufficient acquired malaria
immunity patients, some questions must be addressed
about the pathogenesis of this severe form of malaria
and the immunity status of children who develop
haemoglobinuria. The present study shows that children
with haemoglobinuria have low parasitaemia compared
to those without haemoglobinuria, [OR: 3.31 (1.41–7.78)
with p = 0.005]. Many authors support that parasitaemia
is low in BWF and sometimes may be absent [1,2,30].
Therefore, it is likely that the parasitaemia alone could
not explain the acute intravascular haemolysis which re-
sults in haemoglobinuria. Other authors reported high
incidence of haemoglobinuria in areas of high malaria
transmission focusing on the coexistence of the parasit-
aemia and level of transmission [29]. This hypothesis
has not been confirmed by subsequent studies, such as
those carried out in Uganda, where no significant differ-
ence was found between the areas of different level of
malaria transmission [30,31]. Other risk factors should
be explored and may be targets of new investigations to
search reasons why acute haemolysis occurs in low para-
sitaemia patients and in low malaria transmission. This
finding supports previous reports showing that BWF isegression
p Adjusted OR
(95%CI)
P
< 0,001 < 0,001
1
50,19(10,75–234,42)
0,017 0,115
1
0,39(0,12–1,27)
0,005 0,012
1
0,25(0,08–0,74)
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the intense malaria transmission period [2,32]. It is pos-
sible that parasitaemia alone could not explain acute
intravascular haemolysis that leads to haemoglobinuria
in BWF cases and thus other risk factors including im-
munological and genetics factors should be investigated
to elucidate reasons why acute haemolysis occurs among
patients with low parasitaemia patients and in areas with
low malaria transmission. The high pretreatment levels
can explain low parasitaemia observed during BWF.
BWF may be an acquired immune syndrome and the
role of immunity should be elucidated in the next step
of the study.
Plasmodium falciparum remains the most prevalent
species associated with the occurrence of severe malaria
[2]. In this study, 86% of cases (BWF) were observed to be
infected by P. falciparum as mono-infection, while 14%
had mixed infection of P. falciparum and P. malariae.
Plasmodium malariae is known to cause kidney damage
[33]. It is possible that sudden onset of infection could
have resulted in renal disturbance among P. falciparum
infected children.
In this study, it was observed that there was high fre-
quency of G6PD deficiency (39.5%) among the control
group compared with the cases (18.6%) [OR = 2.86.
(1.86–6.91) p = 0.012] in bi-variate analysis. This enzym-
atic defect is a known major risk factor for the occur-
rence of haemoglobinuria (BWF). This often occurs after
taking oxidant products like quinine, mefloquine and
others. Applying the logistic regression, results show
OR: 0.39 (0.12–1.27). The high frequency of G6PD can
suggest that G6PD may be high in Congolese population
[26] and needs a screening programme to prevent an
acute intravascular haemolysis leading sometimes to
renal failure. G6PD genotyping should be necessary to
get more accurate information about genetics data of
this defect in malaria in this settings.
In addition, the results of this study show a significant
association between quinine ingestion and the occurrence
of haemoglobinuria [OR: 50.19 (10.75–234.42) p < 0.001].
This is in line with previous studies that have reported re-
peated exposure to quinine as a risk factor for BWF
[2,3,19]. Thus, quinine should be avoided in the treatment
of uncomplicated malaria.
In this study, no significant difference was in the level
of LDH, an enzyme also implicated in the genesis of vas-
cular haemolysis, was observed between the two groups.
Since the advent of dialysis, the mortality rate for anuric
acute renal failure (AARF) has changed [13]. The access
to dialysis is, however, limited in many low-resource
countries as is the cases in the DR Congo. All
haemoglobinuric patients who developed AARF died be-
cause peritoneal dialysis was not available or affordable.
This contributes to the high mortality rate of the BWFreported in the DR Congo [23,24]. Furthermore, no sig-
nificant difference was found between the two groups in
the LDH assay in this study, an enzyme also implicated
in the genesis of vascular haemo lysis.
A seasonality of hyperhaemolysis attacks was observed
in the present series. Haemoglobinuria cases occurred
mostly in rainy season than in dry season. This finding
is supported by some authors who reported that BWF is
more prevalent in the malaria endemic area and during
the intense malaria transmission period [2].
Jaundice and pallor manifestations were significantly
associated with haemoglobinuria, which is in accordance
with previous studies on BWF [2,3,19]. Other complains
like oliguria, seizures, comatose, lethargy, dyspnea and
lumbar pain also was significant association with haemo-
globinuria in this study (p < 0.001); low levels of haemo-
globin and packed cell volume (haematocrit) was more
frequent among the haemoglobinuric patients. These re-
sults confirm the acute intravascular haemolysis resulting
in haemoglobinuria and acute renal failure [4].Limitations of the study
The design could have been improved by recruitment of
a severe malaria cohort without haemoglobinuria. Since,
some of the factors such quinine use and rainy season
would be less relevant of compared to this group. This
design leads to another next study. Variables such an-
thropometric parameters and cardiac outcome have not
been investigated.Conclusion
Rainy season [OR: 5.22 (1.87–14.46) p < 0.001], a low
parasitaemia [OR: 0.25 (0.08–0.74), p < 0.05 ] and the in-
gestion of quinine [OR: 50.39 (10.75–234.42), p < 0.001]
were the major risk factors associated with haemo-
globinuria in this study. Among children with severe
malaria, jaundice, severe anaemia and acute renal failure
with elevated creatinine were the most common compli-
cations of BWF observed in the acute intravascular
haemolysis compared to uncomplicated malaria. Im-
munology and genetics factors should be investigated to
get more information about the risk factor of BWF in in-
digenous population in the endemic malaria areas.Competing interests
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